Möchten Sie immer auf dem neuesten Stand bleiben?

$154.2 million in total fourth quarter revenues, net, and $502.1 million in full year revenues, net, primarily comprised of net product revenue of $146.0 million and $362.4 million,...

2025 Fourth Quarter Revenue of $542.6 Million, up 12.7% year-over-yearQ4 Diluted EPS (GAAP) of $0.38, up 21.8% from $0.31 in Q4 of 2024Q4 Adjusted Diluted EPS (Non-GAAP) (1) of $0.50, up 15.0% from...

Approval in adults and children aged 6 years and older supported by Phase 3 trial demonstrating Dupixent significantly reduced nasal signs and symptoms, and systemic corticosteroid use or surgery...

Sanofi and Regeneron’s Dupixent approved in the US as the first and only medicine for allergic fungal rhinosinusitis Approval in adults and children aged 6 years and older supported by phase 3 study...

AUSTIN, Texas, Feb. 23, 2026 (GLOBE NEWSWIRE) -- AINewsWire Editorial Coverage: Artificial intelligence (AI) Enhanced service robotics is rapidly shifting from experimental prototypes toward...

TORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) today released its fourth quarter and full year 2025 financial results and announced 2026...

2025 Full-Year ResultsPress release – Paris, February 20, 2026 at 7:30am CET 2025: Another year of strong delivery FY 2025 sales of €27,283m up +4.5% on a like-for-like (LFL) basis, with volume/mix...

SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results...

Increases 2026 capital return objectives to up to $800 million and renews normal course issuer bid TORONTO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Altus Group Limited (ʺAltus Group” or “the Company”)...

Akamai reports its fourth quarter 2025 and full-year 2025 financial results